MMSC
First Trust Multi-Manager Small Cap Opportunities ETF
MMSC is an actively managed ETF that utilizes a multi-manager approach to provide exposure to small-cap US growth stocks.
US
EQUITY
Active
MANAGEMENT STYLE
$ 51.3 M
ASSETS UNDER MGMT
95 bp
EXPENSES
Fund Basics
| Inception date | Oct 13, 2021 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| US DOLLAR | 2.4 % |
| CRINETICS PHARMACEUTICALS INC | 1.8 % |
| XOMETRY, INC. CLASS A | 1.6 % |
| NLIGHT, INC. | 1.4 % |
| TRAVERE THERAPEUTICS, INC. | 1.3 % |
| FIRSTCASH, INC. | 1.2 % |
| TWIST BIOSCIENCE CORP. | 1.2 % |
| GUARDANT HEALTH, INC. | 1.2 % |
| SPYRE THERAPEUTICS INC | 1.1 % |
| SILICON MOTION TECHNOL-ADR | 1.1 % |
Constituent Breakdown
| Number of holdings | 209 |
| Herfindahl-Hirschman Index | 67 |
| Wgt avg mkt cap (mns) | $8,199 |
| Large cap (>$10bn) | 26.1% |
| Mid cap ($2-10bn) | 60.1% |
| Small cap (<$2bn) | 8.5% |
| Developed mkts. | 95.2% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
| UNITED STATES | 89.1 % | |
| ISRAEL | 1.3 % | |
| HONG KONG | 1.1 % | |
| CANADA | 1.0 % | |
| IRELAND | 1.0 % | |
| BRITAIN | 0.6 % |
Historical Performance
Standardized Performance (as of 06/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 23.4% | 43.2% | 23.7% | 22.3% | -- | -- | -- | 8.0% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | -- | 0.0% |
| Total Returns | 23.4% | 43.2% | 23.7% | 22.3% | -- | -- | -- | 8.0% | Ann. Volatility | 26.0% | 23.6% | 25.1% | 22.8% | -- | -- | -- | 24.6% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.57 | 69% |
| MSCI EAFE | 1.05 | 48% |
| MSCI Emg Mkts | 0.76 | 54% |
Liquidity Measures
| Avg. volume (000) | 5 |
| ADV traded (mns) | $0 |
| Turnover | 0.3% |
| Avg. Bid/Ask (% of price) | 0.43% |
Technical Indicators
| 30d moving avg. (EMA) | $28.31 |
| Relative strength (RSI) | 51 |
| MACD/Signal | 0.05/0.20 |
| Bollinger Bands (Upper/Lower) | $29.45/$27.90 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MMSC |
Expenses vs. MMSC |
ALTAR Score™ vs. MMSC |
|---|---|---|---|---|
| VBK | Vanguard Small-Cap Growth ETF | 23.8% | -88 bp | +1.9% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 23.1% | -25 bp | +2.9% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 22.8% | -89 bp | +3.3% |
| IWO | iShares Russell 2000 Growth ETF | 20.0% | -71 bp | +1.2% |
| PSC | Principal U.S. Small-Cap ETF | 18.9% | -57 bp | +4.6% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 17.7% | -56 bp | +3.9% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 17.4% | -31 bp | +2.4% |
| FESM | Fidelity Enhanced Small Cap ETF | 17.4% | -67 bp | +2.8% |
| VTWG | Vanguard Russell 2000 Growth ETF | 17.2% | -85 bp | +1.4% |
| DBSC | Deepwater Beachfront Small Cap ETF | 17.2% | -10 bp | +2.3% |
Risk and Returns: MMSC vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 7/21/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
0.1%
ALTAR SCORE™
1st
PERCENTILE
AVOID
ETFRC RATING
There are 1,398 funds in the US Equity category with an average
ALTAR Score™ of 5.4% and a standard deviation
of 2.1%. MMSC's ALTAR Score™ is approximately -2.6 standard
deviations above the category average. This places MMSC in the 1st percentile
among funds in the category.
Sell-Side Consensus
$29.58
PRICE TARGET
+6.8%
UPSIDE